Home > Healthcare > Medical Devices > Therapeutic Devices > electron beam linear accelerators market
Get a free sample of Electron Beam Linear Accelerators Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Electron Beam Linear Accelerators Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Technological advancements in cancer treatment, particularly in electron beam linear accelerators, are revolutionizing the way tumors are targeted and treated.
The high-energy machine segment reached USD 406.4 million in 2023, due to offering advanced treatment capabilities.
The market size of electron beam linear accelerators reached USD 709.2 million in 2023 and is set to witness 5.7% CAGR from 2024 to 2032, owing to rise in the prevalence of cancer related disorders, coupled with increasing applications in medical domain worldwide.
Energy Sciences Inc., IntraOp Medical, Inc., Ion Beam Applications SA, Mevex (STERIS), Mitsubishi Electric Corporation, S.I.T. Sordina IORT Technologies S.p.A., Telemark, and Varian Medical Systems, Inc, are some of the major electron beam linear accelerators companies worldwide.
North America market was valued at USD 266 million in 2023, attributed to increased awareness about the benefits of radiation therapy and the availability of advanced treatment options in the region.